切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - MLK3 - 5-HT7 Receptors - CXCR - dopamine receptor

12件产品中的 1-10

页面
每页
清除全部
  1. URMC-099
    B4877 URMC-099
    Target: MLK3
    Summary: MLK3抑制剂
      ≥21.1 mg/mL
      insoluble in H2O
  2. SCH 23390 hydrochloride
    B6506 SCH 23390 hydrochloride
    Target: dopamine receptor|5-HT1 Receptor|5-HT2 Receptor
    Summary: 多巴胺受体拮抗剂
      Soluble to 100 mM in sterile water and to 50 mM in ethanol
  3. Lurasidone HCl
    B1477 Lurasidone HCl
    中文名: 盐酸鲁拉西酮
    Target: 5-HT2 Receptors|D2 Receptors|5-HT1 Receptors|5-HT7 Receptors
    Summary: 多巴胺D2/5-HT2A/5-HT7/5-HT1A抑制剂
      ≥11.11 mg/mL
      insoluble in H2O
  4. Quetiapine Fumarate
    B1490 Quetiapine Fumarate
     1 Citation
    中文名: 富马酸奎硫平
    Target: 5-HT2 Receptors|D1 and D5 Receptors|D2 Receptors|D3 Receptors|5-HT1 Receptors|5-HT7 Receptors
    Summary: 多巴胺受体拮抗剂
      ≥11.03 mg/mL
      insoluble in H2O
  5. Plerixafor 8HCl (AMD3100 8HCl)
    B1465 Plerixafor 8HCl (AMD3100 8HCl)
    中文名: 普乐沙福八盐酸盐
    Target: CXCR
    Summary: CXCR4拮抗剂
      insoluble in DMSO
      ≥155.4 mg/mL
  6. WZ811
    B1466 WZ811
    Target: CXCR
    Summary: 高效的CXCR4竞争性拮抗剂
      ≥15.02 mg/mL
      insoluble in H2O
  7. Vortioxetine
    A3926 Vortioxetine
    中文名: 沃替西汀
    Target: 5-HT1 Receptors|5-HT7 Receptors|5-HT3 Receptors|SERT
    Summary: 5-HT受体拮抗剂
      ≥14.92 mg/mL
      insoluble in H2O
  8. SCH 563705
    A3803 SCH 563705
    Target: CXCR
    Summary: CXCR2/CXCR1拮抗剂
      Soluble in DMSO
  9. SCH 527123
    A3802 SCH 527123
     5 Citation
    Target: CXCR
    Summary: CXCR1和CXCR2拮抗剂
      ≥19.85 mg/mL
      insoluble in H2O
  10. Reparixin L-lysine salt
    A3753 Reparixin L-lysine salt
     1 Citation
    中文名: 瑞帕利辛L-赖氨酸盐
    Target: CXCR
    Summary: CXCL8受体CXCR1/CXCR2活化的抑制剂
      insoluble in DMSO
      ≥16.67 mg/mL

12件产品中的 1-10

页面
每页